Development

An under-the-skin implant would make GLP-1 therapy twice-yearly

development2026-07-11

Claim

Vivani's under-the-skin semaglutide implant would make GLP-1 therapy a twice-yearly firmware update, while Xreal packed a 147-inch virtual screen into 62-gram $299 glasses.

Reported metric: 62 g / $299

Reporting date: 2026-07-11 (not necessarily the event date)

Sources

Attribution and reporting linked by this record; links do not imply independent verification.

Welcome to July 11, 2026 (theinnermostloop.substack.com)

Knowledge graphopen in browser →

Reported in

Welcome to July 11, 2026

Actor

Evidence for

Supersedes

An annual pipeline report counts 158 Alzheimer's drugs across 192 trials

Referenced by

Cite or correct this record

Citation formatCitation text

An under-the-skin implant would make GLP-1 therapy twice-yearly
Innermost Loop KB — secondary record
Reporting date: 2026-07-11
KB permalink: https://nicholsn.github.io/innermost-loop-kb/developments/2026-07-11-a-glp-1-implant-as-a-twice-yearly-update
Claim: Vivani's under-the-skin semaglutide implant would make GLP-1 therapy a twice-yearly firmware update, while Xreal packed a 147-inch virtual screen into 62-gram $299 glasses.
Attributed sources:
- Welcome to July 11, 2026 — https://theinnermostloop.substack.com/p/welcome-to-july-11-2026
This citation does not imply independent verification of linked-source claims.

Suggest a correction — opens a GitHub draft for you to review and submit.